🇺🇸 FDA

Intelligence · Patent portfolio

Sunshine Guojian Pharmaceutical Patents

Full USPTO pharma patent portfolio for Sunshine Guojian Pharmaceutical — grant dates, expiration, and drug cross-links.

Patents
121
Expiring ≤24m
0

Quick answer

Sunshine Guojian Pharmaceutical has 121 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 3

  1. US 12428432

    Thienopyrimidine derivatives having stereo configurations and use thereof in medicine

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12428389

    Diarylamide compound and application thereof

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12384853

    Anti-HER2/PD1 bispecific antibody

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12324812

    Glucopyranosyl derivatives and their uses

    Expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12319748

    Antibody binding to human HER2 and preparation method and use thereof

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12312348

    RET inhibitors, pharmaceutical compositions and uses thereof

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12269886

    Tetravalent bispecific antibody against PD-1 and PD-L1

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12258317

    Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12209085

    RET inhibitors, pharmaceutical compositions and uses thereof

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12194065

    Methods and compositions to enhance metabolic detoxification systems

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12171761

    Vilazodone inclusion complexes, compositions and preparation thereof

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12145974

    Dual-target fusion proteins comprising FGF21 and GLP-1, connected through a Fc portion of an immunoglobulin

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12128044

    Fused tricyclic compounds and uses thereof in medicine

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11858910

    Pyridinylmethylenepiperidine derivatives and uses thereof

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11679143

    FGF21 variant, fusion protein and application thereof

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11667717

    Antibodies binding to human IL-4R, preparation method therefor and use thereof

    Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11517569

    Vilazodone inclusion complexes, compositions and preparation thereof

    Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11447498

    Fused tetracyclic compounds and uses thereof in medicine

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11396495

    Amine compound for inhibiting SSAO/VAP-1 and use thereof

    Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11370836

    Monoclonal antibody binding to human IL-5, preparation method therefor and use thereof

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11331363

    Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, dietary supplements, cosmetics and pharmaceutical preparations

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11285153

    Substituted pyrimidine piperazine compound and use thereof

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11261190

    Dihydropyrimidine compounds and uses thereof in medicine

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11254746

    Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11241406

    Compositions and methods for acutley raising nitric oxide levels

    Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11242335

    Fluorine-substituted indazole compounds and uses thereof

    Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11225477

    Inhibitors of influenza virus replication, application methods and uses thereof

    Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11225460

    Pyrrolidineamide derivatives and uses thereof

    Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11213529

    Salt of substituted urea derivative and use thereof in medicine

    Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11208418

    Nitrogenous tricyclic compounds and uses thereof in medicine

    Expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11186602

    Glucopyranosyl derivative and use thereof

    Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11179376

    Salts of pyrazolo[1,5-a]pyridine derivative and use thereof

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11142527

    Dihydropyrimidine compounds and uses thereof in medicine

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11122832

    Methods and compositions to improve weight loss and cardiometabolic health beyond diet and excercise

    Expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11104689

    Influenza virus replication inhibitor and use thereof

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11098042

    Inhibitors of influenza virus replication and uses thereof

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11090272

    Lurasidone solid dispersion and preparation method thereof

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11084842

    Glucopyranosyl derivative and use thereof

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10987354

    Inhibitors of influenza virus replication and uses thereof

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10966970

    Fused tricyclic compounds and uses thereof in medicine

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10927089

    Diaryl thioether piperazine compounds, preparation methods and uses thereof

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10927118

    Inhibitors of influenza virus replication and uses thereof

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10800734

    Memantine compounds and their preparation and uses thereof

    Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10759812

    Thienopyrimidine derivative and use thereof in medicine

    Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10751339

    Substituted aminopyrimidine compounds and methods of use

    Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10738112

    Anti-human interleukin-17A monoclonal antibody

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10717732

    Inhibitors of influenza virus replication, application methods and uses thereof

    Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10688090

    Vilazodone inclusion complexes, compositions and preparation thereof

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Sunshine Guojian Pharmaceutical have?

121 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Sunshine Guojian Pharmaceutical patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.